Imran Vhora

Imran Vhora

Auto-generated profile, based on publicly available information

Imran Vhora

College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, Florida, 32307, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
AKAtul Kolate
Atul Kolate
DBDipesh Baradia
Dipesh Baradia
SPSushilkumar Patil
Sushilkumar Patil
IVImran Vhora
Imran Vhora
GKGirish Kore
Girish Kore
AMAmbikanandan Misra
Ambikanandan Misra

1 November 2013 in Biomaterials
Verified
Journal Article
Closed access
CYChetan Yewale
Chetan Yewale
DBDipesh Baradia
Dipesh Baradia
IVImran Vhora
Imran Vhora
SPSushilkumar Patil
Sushilkumar Patil
AMAmbikanandan Misra
Ambikanandan Misra

1 January 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
PBPriyanka Bhatt
Priyanka Bhatt
RLRohan Lalani
Rohan Lalani
IVImran Vhora
Imran Vhora
SPSushilkumar Patil
Sushilkumar Patil
JAJitendra Amrutiya
Jitendra Amrutiya
RMRajashree Mashru
Rajashree Mashru

1 January 2015
Verified
Book Chapter
Closed access
IVImran Vhora
Imran Vhora
SPSushilkumar Patil
Sushilkumar Patil
PBPriyanka Bhatt
Priyanka Bhatt
AMAmbikanandan Misra
Ambikanandan Misra

22 June 2013 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
CYChetan Yewale
Chetan Yewale
DBDipesh Baradia
Dipesh Baradia
IVImran Vhora
Imran Vhora
AMAmbikanandan Misra
Ambikanandan Misra
Introduction: Over the past decades, proteins have emerged as versatile carriers for the diagnosis and treatment of cancer, diabetes, rheumatoid arthritis, and many more diseases. Proteins have gained considerable attention in formulation of several delivery systems for anticancer drugs due to their nontoxic, non-immunogenic, biocompatible and biodegradable nature. Proteins are good candidates for conjugation with drugs as they provide good pharmacokinetics as well as better cancer tissue accumulation. Protein nanoparticulate systems are also of advancing importance owing to their modifiable functionalities and potential applications in various biological fields. The customizable nature of proteins also makes them outstanding carriers as target-specific delivery systems. Areas covered: This review emphasizes on protein conjugates (drug-albumin, drug-gelatin, drug-transferrin, and drug-antibody conjugates), protein nanoparticles (prepared using albumin, gelatin, casein, silk proteins, elastin, and lectins), surface modification of protein nanoparticles (using surfactant, polyethylene glycol, cationic/thermosensitive polymers, folic acid, monoclonal antibodies, and peptides/proteins), and their preclinical and clinical status with respect to cancer therapy. Expert opinion: The major obstacles for commercial success of protein-based delivery are lack of inexpensive as well as quality methods for their preparation and quality control; and if overcome, proteins will stand out as a superior drug-delivery carrier for cancer therapy.

1 May 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
IVImran Vhora
Imran Vhora
RLRohan Lalani
Rohan Lalani
PBPriyanka Bhatt
Priyanka Bhatt
SPSushilkumar Patil
Sushilkumar Patil
AMAmbikanandan Misra
Ambikanandan Misra